Register

Registration

Disclaimer
Terms and Conditions
Questionnaires / Survey
Note : After Answered of Questionnaires / Survey Please Close it.
.

Kilitch Drugs (India) Ltd . Small Cap

BSE: 524500 | NSE: KILITCH
Pharmaceuticals
Live
15/04/2021 12:50:00 PM
107.00 -1.10   (-1.02%)
BSE: price shown with 5 mins delayed.
Prev. Close 108.10
Open Price 110.00
Volume Traded 1759.00

Fundamentals

Mar'11 Mar'12 Mar'13 Mar'14 Mar'15 Mar'16 Mar'17 Mar'18 Mar'19 Mar'20
Ajusted EPS(Rs.) 7.76 52.81 0 0 0 3.75 2.49 0.55
Net Sales (Rs. Cr.) 146.31 107.97 19.03 20.99 28.65 51.01 82.49 53.32
Adjusted Net Profit 10.49 4.58 -0.76 -10.79 -8.94 4.26 2.81 -0.21
Book Value/ Share(Rs.) 63.72 86.58 90.6 82.14 76.48 81.58 78.84 76.62
Cash Flow 5.54 2.18 -38.87 -2.24 -0.45 2.48 3.17 -5.13
Debt to Cash Flow from Operations 0.71 -0.30 0.00 0.01 0.62 0.65 32.62 3.36
RONW 13.03 4.55 -0.64 -9.79 -8.47 3.99 2.41 -0.18
ROCE % 15.17 7.76 -1.15 -10.12 -8.69 5.09 5.70 0.56
Net Operating Profit Margin % 12.59 9.69 2.26 -7.53 1.54 13.91 10.13 3.36
Net Profit Margin % 7.06 4.14 -4.05 -53.31 -31.03 8.33 3.41 -0.39
Debt / Equity 0.36 0.12 0.00 0.00 0.00 0.01 0.04 0.09
Dividend Yield % 1.67 49.19 0.00 0.00 0.00 0.26 0.51 0.00
Mar'11 Mar'12 Mar'13 Mar'14 Mar'15 Mar'16 Mar'17 Mar'18 Mar'19 Mar'20
Ajusted EPS(Rs.) 7.74 54.04 2.48 0.89 0 0 0 4.51 9.62 2.89
Net Sales (Rs. Cr.) 146 106.86 33.18 14.9 19.03 21.02 28.14 50.46 96.42 60.77
Adjusted Net Profit 10.46 5.89 3.65 -2.67 -0.63 -1.65 -0.09 5.28 13.05 2.91
Book Value/ Share(Rs.) 63.83 87.49 78.5 90.86 90.67 89.12 89.95 93.82 98.39 98.25
Cash Flow 5.68 2.31 -8.70 40.91 -38.88 -2.46 -0.35 1.71 0.21 -1.35
Debt to Cash Flow from Operations 2.43 -0.03 0.00 0.00 0.00 0.01 1.07 -0.62 1.26 1.72
RONW 0.00 0.00 3.32 -2.37 -0.53 -1.39 -0.08 4.22 9.25 1.92
ROCE % 13.11 8.18 3.37 -2.45 -1.04 -1.71 -0.30 5.17 12.22 2.67
Net Operating Profit Margin % 12.59 11.25 14.68 -8.99 2.94 -2.28 2.88 14.45 19.14 7.50
Net Profit Margin % 7.05 5.38 11.00 -17.85 -3.36 -7.85 -0.32 10.46 13.53 4.79
Debt / Equity 0.60 0.27 0.00 0.00 0.00 0.00 0.00 0.01 0.04 0.07
Dividend Yield % 1.67 49.19 0.00 0.00 0.00 0.00 0.00 0.27 0.51 0.00

Year on Year Growth Rate (%)

Ajusted EPS Sales Adjusted Net Profit

Latest Financials

Standalone Consolidated
TTM EPS (Rs) 3.11 1.11
TTM Sales (Rs. Cr.) 61.75 60.21
BVPS (Rs.) 101.12 78.72
Reserves (Rs. Cr.) 141.19 106.48
P/BV 1.06 1.36
PE 34.76 97.38739
From the Market
52 Week High / Low (Rs) 138.5/78.25
All Time High / Low (Rs) 208.15/0.75
Volume Traded 1759
Market Cap (Rs. Cr.) 167.5
Equity (Rs. Cr.) 15.494544
Face Value (Rs) 10
Industry PE 0

Quarterly Results

Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr) 12.87 10.37 18.19 20.32
Adjusted EPS (Rs) -0.31 -0.35 1.75 2.01
Net Profit Margin % -3.73 -5.21 14.90 15.35
Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr) 11.62 10.19 18.07 20.33
Adjusted EPS (Rs) -0.81 -0.86 1.34 1.43
Net Profit Margin % -10.76 -13.05 11.51 10.87

Quarterly Growth Rate (%)

Ajusted EPS Sales Net Profit Margin

Peers Data

Name Current Price(Rs) Market Cap. (Rs. cr.) Net Profit(Rs. cr.) Sales Growth(%)
Gujarat Terce Laboratories Ltd 7.61 5.94 0.28 -48.69
Parnax Lab Ltd 19.25 17.21 0 -79.17
Medi Caps Ltd 40 48.45 -8.33 -100.00
Lyka Labs Ltd 25.5 76.89 -53.19 -10.42
Ambalal Sarabhai Enterprises Ltd 19.5 145.6 0 0.00
Kilitch Drugs (India) Ltd 107 167.5 4.46 -19.55
Aurobindo Pharma Ltd 925.7 53305.76 1872.74 -11.37
Cipla Ltd 911.5 71388.13 2318.17 -39.44
Dr Reddys Laboratories Ltd 4835.8 79502.06 2937.7 -15.73
Divis Laboratories Ltd 3800 98760.95 1372.71 -4.34
Sun Pharmaceuticals Industries Ltd 634.8 150534.28 3211.14 -20.62

Technical

Sector

22607.36 207.54   (0.93%)

Index

48292.11 -251.95   (-0.52%)
9 Days Avg
Span A Span B 52 Week TenKan-Sen Kijun-Sen ChiKou-Sen
9 Days Avg

Score

Kindly subscribe to get access

Research Analytical

Kindly subscribe to get access

News

About Company

Incorporated in May '92 as a public limited company, Kilitch Drugs (India) (KDIL) went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct.'95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical.A Pharmaceutical formulation plant at Sana'a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation.It also entered into an agreement with a Miami company for the export of their medicine to West Indies, south and central America.The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5-cr tanning unit, which was implemented in the year 1995-96. The company had set up a bulk drug unit at Patalganga, Maharashtra for producing raw materials for formulations. The company exports to Sudan, Yemen, middle-east, Miami and certain south American companies. KDIL started marketing a range of injectables from the factory on ethical basis. The company also introduced a new product clue-plus, Bon-Bon Gripe Water and Kilitch Balm.